Analysis of the clinical antibacterial and antituberculosis pipeline

Ursula Theuretzbacher, Simon Gottwalt, Peter Beyer, Mark Butler, Lloyd Czaplewski, Christian Lienhardt, Lorenzo Moja, Mical Paul, Sarah Paulin, John H Rex, Lynn L Silver, Melvin Spigelman, Guy E Thwaites, Jean-Pierre Paccaud, Stephan Harbarth

Open source

DOI
10.1016/s1473-3099(18)30513-9
Published
2019-02
Container
The Lancet Infectious Diseases
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-18-30513-9,
  title = {Analysis of the clinical antibacterial and antituberculosis pipeline},
  author = {Ursula Theuretzbacher and Simon Gottwalt and Peter Beyer and Mark Butler and Lloyd Czaplewski and Christian Lienhardt and Lorenzo Moja and Mical Paul and Sarah Paulin and John H Rex and Lynn L Silver and Melvin Spigelman and Guy E Thwaites and Jean-Pierre Paccaud and Stephan Harbarth},
  year = {2019},
  journal = {The Lancet Infectious Diseases},
  doi = {10.1016/s1473-3099(18)30513-9},
  url = {https://doi.org/10.1016/s1473-3099(18)30513-9}
}

RIS

TY  - JOUR
TI  - Analysis of the clinical antibacterial and antituberculosis pipeline
AU  - Ursula Theuretzbacher
AU  - Simon Gottwalt
AU  - Peter Beyer
AU  - Mark Butler
AU  - Lloyd Czaplewski
AU  - Christian Lienhardt
AU  - Lorenzo Moja
AU  - Mical Paul
AU  - Sarah Paulin
AU  - John H Rex
AU  - Lynn L Silver
AU  - Melvin Spigelman
AU  - Guy E Thwaites
AU  - Jean-Pierre Paccaud
AU  - Stephan Harbarth
PY  - 2019
JO  - The Lancet Infectious Diseases
DO  - 10.1016/s1473-3099(18)30513-9
UR  - https://doi.org/10.1016/s1473-3099(18)30513-9
ER  - 

APA

Theuretzbacher, U., Gottwalt, S., Beyer, P., Butler, M., Czaplewski, L., Lienhardt, C., Moja, L., Paul, M., Paulin, S., Rex, J. H., Silver, L. L., Spigelman, M., Thwaites, G. E., Paccaud, J., & Harbarth, S. (2019). Analysis of the clinical antibacterial and antituberculosis pipeline. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(18)30513-9

Source records